Notify me when Havlickova 648 a.s. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CVKD | Cadrenal Therapeutics, Inc. | Common Stock, par value $0.001 per share | 4.4% | $1,174,365 | 78,291 | Havlickova 648 a.s. | 31 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|